{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["81(13)"],"submitter":["Jin R"],"funding":["NIDDK NIH HHS","National Institute of Diabetes and Digestive and Kidney Diseases"],"journal":["The Prostate"],"pagination":["944-955"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8750893"],"repository":["biostudies-literature"],"pubmed_title":["The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms."],"pmcid":["PMC8750893"],"funding_grant_id":["R01 DK115477","5R01 DK111554","R01 DK111554","U54 DK104310"],"pubmed_authors":["Ramirez-Solano M","Matusik RJ","Jin R","Case T","Cates JMM","Sanchez S","Liu Q","Strand DW","Milne GL","Miller NL","Bjorling DE","Forbes CM","Wang ZY"],"additional_accession":[]},"is_claimable":false,"name":"The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.","description":null,"dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Sep","modification":"2025-04-22T21:12:13.955Z","creation":"2025-04-22T21:12:13.955Z"},"accession":"S-EPMC8750893","cross_references":{"pubmed":["34288015"],"doi":["10.1002/pros.24190"]}}